PEG bowel preparation effects on gut microbes after gallbladder removal
Official title: Clinical Experimental Study on the Impact of PEG Laxatives for Intestinal Preparation on Gut Microbiota in Patients Undergoing Cholecystectomy
Run by Tongji Hospital · NCT07439640 · Data updated 2026-11-12
This study tests whether PEG-based colonoscopy prep causes larger or longer-lasting changes to gut microbes in adults who have had their gallbladder removed compared with people who still have their gallbladder.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Tongji Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | January 16, 2025 |
| Main results expected | March 16, 2027 |
| Study ends | March 16, 2027 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT07439640 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 scheduled for colonoscopy with PEG who either had cholecystectomy at least 6 months prior or have an intact gallbladder, and who have not used antibiotics, probiotics, or prebiotics in the previous 6 months are ideal candidates.
✕Probably not a fit
People who recently used antibiotics/probiotics, have major organ disease, are pregnant or breastfeeding, cannot tolerate PEG, or cannot comply with stool collection are unlikely to receive benefit from joining this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, parallel-group observational cohort at Tongji Hospital will enroll about 20 adults, split into roughly 10 with prior cholecystectomy (≥6 months) and 10 age- and sex-matched controls with intact gallbladders. All participants will receive standard PEG-based bowel preparation for colonoscopy and provide stool samples at baseline, at the first non-watery stool after colonoscopy, and at 1, 3, and 6 months post-procedure. Metagenomic shotgun sequencing will be performed to profile taxonomic and functional changes in the microbiome and compare recovery trajectories between groups. Key exclusions include recent antibiotic/probiotic use and major organ disease to reduce confounding factors.
Why it matters
Potential benefit: If successful, the results could help guide colonoscopy preparation and follow-up care to reduce or manage long-term gut microbiota disruptions in people who have had a cholecystectomy.
How similar studies have gone: Animal studies and some human data show that PEG and cholecystectomy can each alter the gut microbiome, but combined effects in humans have not been systematically studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Scheduled to undergo colonoscopy with polyethylene glycol (PEG)-based bowel preparation. * For the gallbladder removal group: prior cholecystectomy performed at least 6 months before enrolment. * For the normal group: intact gallbladder (no history of cholecystectomy). * Willing and able to provide written informed consent. * Willing to collect and mail stool samples at five specified time points (baseline, first non-watery stool after colonoscopy, 1 month, 3 months, 6 months). Exclusion Criteria: * Contraindications to colonoscopy (e.g., severe cardiopulmonary insufficiency, acute gastrointestinal bleeding, severe coagulopathy). * Known intolerance or allergy to polyethylene glycol (PEG). * Use of antibiotics, probiotics, or prebiotics within 6 months prior to enrolment. * Pregnancy or breastfeeding. * Mental disorders or any condition that may compromise the ability to comply with study procedures. * Major organ diseases (e.g., liver cirrhosis, chronic kidney disease stage 4-5, uncontrolled diabetes mellitus). * Participation in another interventional clinical trial within the last 3 months.
Where it's running
-
Department of Gastroenterology Tongji Hospital, Tongji Medical college, Huazhong University of Science and technology
Wuhan, Hubei, China Recruiting
Study contacts
- Study coordinator: ping h Xie
- Email: hpxie@tjh.tjmu.edu.cn
- Phone: 86+13437187007
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing laparoscopic ultrasound and fluorescence imaging with indocyanine green to map bile ducts during difficult laparoscopic gallbladder removal
This will try two imaging methods—laparoscopic ultrasound and fluorescence cholangiography with indocyanine green—in adults having technically difficult laparoscopic gallbladder removal to see which shows the bile duct anatomy best.
-
Real-time AI labeling of critical anatomy during laparoscopic gallbladder removal
This project will try a real-time AI algorithm to label key anatomical structures in laparoscopic cholecystectomy videos to help surgeons avoid bile duct injuries.
-
Robotic versus laparoscopic gallbladder removal for benign gallbladder disease
This trial will test whether robotic gallbladder removal is as safe as standard laparoscopic surgery for adults who need their gallbladder removed for benign disease.
-
How genetic differences affect nalbuphine pain relief after abdominal or pelvic surgery
We will test whether genetic differences change how well nalbuphine relieves pain after abdominal or pelvic surgery in adults.
-
Stanford program to advance robotic surgery for children and adolescents
This program will try the da Vinci Xi surgical robot in children and adolescents (ages 6–21, ≥15 kg) to see if it is safe and works well for procedures like sleeve gastrectomy, cholecystectomy, splenectomy, hysterectomy, and operations for endometriosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.